Galderma Group AG (XSWX:GALD) Equity-to-Asset : 0.62 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Galderma Group AG's Total Stockholders Equity for the quarter that ended in Dec. 2024 was CHF6,946 Mil. Galderma Group AG's Total Assets for the quarter that ended in Dec. 2024 was CHF11,249 Mil. Therefore, Galderma Group AG's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.62.

The historical rank and industry rank for Galderma Group AG's Equity-to-Asset or its related term are showing as below:

XSWX:GALD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.43 Med: 0.52 Max: 0.62
Current: 0.62

During the past 2 years, the highest Equity to Asset Ratio of Galderma Group AG was 0.62. The lowest was 0.43. And the median was 0.52.

XSWX:GALD's Equity-to-Asset is ranked better than
53.27% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs XSWX:GALD: 0.62

Galderma Group AG Equity-to-Asset Historical Data

The historical data trend for Galderma Group AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Equity-to-Asset Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Equity-to-Asset

0.43

0.62

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Equity-to-Asset	-	0.43	0.61	0.62

Competitive Comparison of Galderma Group AG's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's Equity-to-Asset falls into.

Save Embed

;

Save Embed

;

Galderma Group AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Galderma Group AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	6945.564	/	11249.317
	=	0.62

Galderma Group AG's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	6945.564	/	11249.317
	=	0.62

Galderma Group AG (XSWX:GALD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Galderma Group AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Equity-to-Asset

Traded in Other Exchanges

GALDY:USA GDERF:USA GALDz:UK PY30:Germany

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines